Allergy Therapeutics plc (AIM: AGY)

Allergy Therapeutics Revenue

In the fiscal year ending June 30, 2024, Allergy Therapeutics had annual revenue of 55.20M GBP, down -7.36%. Allergy Therapeutics had revenue of 21.63M in the half year ending June 30, 2024, a decrease of -10.16%.

• Revenue: 55.20M
• Revenue Growth: -7.36%
• P/S Ratio: 3.73
• Revenue / Employee: 90.19K
• Employees: 612
• Market Cap: 262.70M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	55.20M	-4.39M	-7.36%
Jun 30, 2023	59.59M	-13.18M	-18.11%
Jun 30, 2022	72.77M	-11.56M	-13.71%
Jun 30, 2021	84.33M	6.13M	7.83%
Jun 30, 2020	78.20M	4.49M	6.09%